Fresh-blood immune profiling of immune-related adverse events in real-world patients identifies organ-specific and steroid responsiveness signatures
Immuno-Oncology and Technology · 2026-06 · 30 · 101587
DOI: 10.1016/j.iotech.2026.101587 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immuno-Oncology and Technology, 2026-06. Verfasst von M Velasco Santiago und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Center of Cancer Immune Therapy, CCIT-DK, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Novo Nordisk Foundation.
Themen: Patientensicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Center of Cancer Immune Therapy, CCIT-DK, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
Förderung
- Novo Nordisk Foundation
Zitieren
APA
Velasco Santiago, M., Jurlander, R. S., Albieri, B., Noringriis, I. M., Sohlin, J. E., Kverneland, A. H., & Svane, I. M. (2026). Fresh-blood immune profiling of immune-related adverse events in real-world patients identifies organ-specific and steroid responsiveness signatures. Immuno-Oncology and Technology, 30, 101587. https://doi.org/10.1016/j.iotech.2026.101587
Vancouver
Velasco Santiago M, Jurlander RS, Albieri B, Noringriis IM, Sohlin JE, Kverneland AH, et al. Fresh-blood immune profiling of immune-related adverse events in real-world patients identifies organ-specific and steroid responsiveness signatures. Immuno-Oncology and Technology. 2026;30:101587. doi:10.1016/j.iotech.2026.101587
BibTeX
@article{VelascoSantiago2026,
author = {Velasco Santiago, M and Jurlander, R S and Albieri, B and Noringriis, I M and Sohlin, J E and Kverneland, A H and Svane, I M},
title = {Fresh-blood immune profiling of immune-related adverse events in real-world patients identifies organ-specific and steroid responsiveness signatures},
journal = {Immuno-Oncology and Technology},
year = {2026},
volume = {30},
pages = {101587},
doi = {10.1016/j.iotech.2026.101587}
}
EUVIMED